CRISPR, The New Gold Standard?Understanding The Rise Of Genetic Engineering In India – Part 2. Legal News and Analysis - ...

An India-based chemical manufacturing firm, Vasudha Pharma Chem Limited, and its high-level employees face charges in a US federal court for illegally importing precursor chemicals used to make ...

On Tuesday, India’s top specialty generics company Sun Pharma announced the acquisition of the US-based Checkpoint for $355 million to enhance its oncology portfolio. Analysts view this ...

Diego Garcia, a remote Indian Ocean island nearly 2,000 miles from the East African coast, boasts clear-blue waters, pristine beaches — and a US-UK military base at the heart of the great-power ...

Vice President JD Vance will travel to India later this month alongside Second Lady Usha Vance, according to three sources familiar with the plans. It marks Vance’s second foreign trip as vice ...

It is time for the ultimate showdown as India and New Zealand lock horns in the final of the 2025 ICC Champions Trophy in Dubai on Sunday. India have been the best team in the tournament having ...

Currently, only the oral version of semaglutide, marketed as Rybelsus is available in India, whereas the injectable Wegovy is yet to be launched. Salil Kallianpur, a pharmaceutical analyst ...

Knight Therapeutics Inc. GUD-T has signed a deal to buy the assets of Paladin Pharma Inc. as the Canadian drug company looks to build out its domestic business after a strategic push into South ...

The diabetes care landscape in India is set for a major transformation as domestic pharmaceutical companies reportedly prepare to launch low-cost generic versions of Empagliflozin. The move comes ...

Estimated to significantly cut costs and improve access for over 10 crore diabetics, Mankind Pharma and others will offer the drug at a fraction of its original cost, easing financial burdens and ...

On Sunday, India-based Sun Pharmaceutical Industries Limited agreed to acquire U.S.-based immunotherapy and targeted oncology company Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) for an upfront ...

Sun Pharma has agreed to purchase the Massachusetts biotech for an upfront value of $355 million, or $4.10 per share, the companies said Sunday. With Unloxcyt, an FDA-approved PD-L1 therapy for ...